Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)

NCT05205525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2023-03-08

No results posted yet for this study

Summary

This retro-prospective monocentric observational study compare the impact of the implementation of a restrictive (delayed) versus aggressive (immediate) antibiotic strategy for Ventilator Acquired Pneumonia suspicion without severity symptoms.

Conditions

  • Ventilator Associated Pneumonia
  • Critical Care
  • Antibiotic Therapy

Interventions

OTHER

Restrictive antibiotic strategy

Implementation of a restrictive (delayed) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.

OTHER

Aggressive antibiotic strategy

Implementation of an aggressive (immediate) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-06
Primary Completion
2023-01-28
Completion
2023-01-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205525 on ClinicalTrials.gov